Merck to submit its experimental COVID-19 oral treatment for emergency use authorization

Merck to submit its experimental COVID-19 oral treatment for emergency use authorization – CBS News

Watch CBSN Live


Pharmaceutical company Merck says its experimental pill significantly reduces the effects of COVID-19 and plans to submit its findings to the Food and Drug Administration for emergency use authorization. CBS News researcher Max Bayer speaks with CBSN’s Tanya Rivero about how this drug differs from those already in use.

View CBS News In

Be the first to know

Get browser notifications for breaking news, live events, and exclusive reporting.